Dengue Vaccines, Antiviral Therapeutics and Emerging Diagnostic Biomarkers: Advances, Constraints and Translational Priorities
Dengue control is entering a period in which vaccination, direct-acting antiviral development and increasingly sophisticated diagnostics can no longer be evaluated as separate technical domains. Vaccine performance is shaped by baseline dengue serostatus, circulating serotype and duration of follow-up; antiviral effica...